A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment

Drug Development and Industrial Pharmacy

Volumn 41, Issue 7, 2015, Pages 1193-1203

  Bao, Xu ^a   Gao, Meng ^a   Xu, Hong ^a   Liu, Ke Xin ^a   Zhang, Cheng Hong ^a   Jiang, Ni ^b   Chu, Qiu Chen ^a   Guan, Xin ^a   Tian, Yan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Dalian Children Hospital   (China)

Author keywords

cellular uptake; Characterization; cytotoxicity; HepG2; therapeutic effect

Indexed keywords

FLUOROURACIL; NANOCARRIER; OLEANOLIC ACID; POLY(LACTIDE CO GLYCOLIDE) DEXTRO ALPHA TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE; UNCLASSIFIED DRUG; ALPHA TOCOPHEROL; ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE; ANTINEOPLASTIC AGENT; COUMARIN 6; COUMARIN DERIVATIVE; DELAYED RELEASE FORMULATION; DRUG CARRIER; LACTIC ACID; MACROGOL DERIVATIVE; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; THIAZOLE DERIVATIVE;

ARTICLE; CANCER GROWTH; CANCER SIZE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FLUORESCENCE MICROSCOPY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HYDROPHILICITY; IC50; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LIVER CANCER CELL LINE; NANOEMULSION; NANOENCAPSULATION; PARTICLE SIZE; SURFACE CHARGE; SUSTAINED DRUG RELEASE; THERAPY EFFECT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DRUG RELEASE; LIVER NEOPLASMS; PATHOLOGY; SOLUBILITY;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; COUMARINS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG LIBERATION; HEP G2 CELLS; HUMANS; LACTIC ACID; LIVER NEOPLASMS; NANOPARTICLES; OLEANOLIC ACID; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; SOLUBILITY; THIAZOLES; VITAMIN E;

EID: 84932603380     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.938081     Document Type: Article

References (53)

1. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002;35:S72-8.
2. Rossi L, Zoratto F, Papa A, et al. Current approach in the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2010;2:348-59.
3. Doyle MB, Vachharajani N, Maynard E, et al. Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes. J Am Coll Surg 2012;215:19-28.
4. Li S, Hawxby AM, Kanagala R, et al. Liver transplantation for hepatocellular carcinoma: indications, bridge therapy and adjuvant therapy. J Okla State Med Assoc 2012;105:12-16.
5. Nussbaumer S, Bonnabry P, Veuthey JL, et al. Analysis of anticancer drugs: a review. Talanta 2011;85:2265-89.
6. Hossain DM, Bhattacharyya S, Das T, Sa G. Curcumin: the multitargeted therapy for cancer regression. Front Biosci (Schol Ed) 2012;4:335-55.
7. Manchun S, Dass CR, Sriamornsak P. Targeted therapy for cancer using pH-responsive nanocarrier systems. Life Sci 2012;90:381-7.
8. Tsuruga T, Chun YT, Ebizuka Y, Sankawa U. Biologically active constituents of Melaleuca leucadendron: inhibitors of induced histamine release from rat mast cells. Chem Pharm Bull 1991;39:3276-8.
9. Balanehru S, Nagarajan B. Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem Int 1991;24:981-90.
10. Zhang YN, Zhang W, Hong D, et al. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities. Bioorg Med Chem 2008;16:8697-705.
11. Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 2001;16:S28-37.
12. Yan SL, Huang CY, Wu ST, Yin MC. Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines. Toxicol In Vitro 2010;24:842-8.
13. Shyu MH, Kao TC, Yen GC. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. J Agric Food Chem 2010;58:6110-18.
14. Ovesná Z, Vachálková A, Horváthová K, Tóthová D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview. Neoplasma 2004;5:327-33.
15. Novotný L, Vachálková A, Biggs D. Ursolic acid: an antitumorigenic and chemopreventive activity. Neoplasma 2001;48:241-6.
16. Zhou S, Xu J, Yang H, Deng X. Synthesis and characterization of biodegradable poly(ε-caprolactone)-poly glycolide-poly(ethylene glycol) monomethyl ether random copolymer. Macromol Mater Eng 2004;289:576-80.
17. Traber MG, Schiano TD, Steephen AC, et al. Efficacy of water-soluble vitamin E in the treatment of vitamin-E malabsorption in short-bowel syndrome. Am J Clin Nutr 1994;59:1270-4.
18. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 2003;86:33-48.
19. Ling Y, Huang YS. Preparation and release efficiency of poly (lactic-co-glycolic) acid nanoparticles for drug loaded paclitaxel. In: Peng Y, Wen X, eds. Seventh Asian-Pacific conference on medical and biological engineering APCMBE. IFMBE Proceedings. Berlin, Heidelberg: Springer; 2008:514-17.
20. Fischer JR, Harkin KR, Freeman LC. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine A in healthy dogs. Vet Ther 2002;3:465-73.
21. Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16:1550-6.
22. Yu L, Bridgers A, Polli J, et al. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res 1999;16:1812-17.
23. Chen H, Zheng Y, Tian G, et al. Oral delivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapy. Nanoscale Res Lett 2011;6:4-14.
24. Ishiyama M, Tominaga H, Shiga M, et al. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharmaceut Bull 1996;19:1518-20.
25. Desai MP, Labhasetwar V, Walter E, et al. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 1997;14:1568-73.
26. Qaddoumi MG, Ueda H, Yang J, et al. The characteristic and mechanisms of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm Res 2004;21:641-8.
27. Mei L, Zhang Y, Zheng Y, et al. A novel docetaxel-loaded poly(ε-caprolactone)/pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment. Nanoscale Res Lett 2009;4:1530-9.
28. Florence AT. Nanoparticle uptake by the oral route: fulfilling its potential? Drug Discovery Today Technol 2005;2:75-81.
29. Norris DA, Puri N, Sinko PJ. The effect of physical barriers and properties on the oral absorption of particulates. Adv Drug Deliv Rev 1998;34:135-54.
30. Zhang ZR, He Q. Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoa-cryslate nanoparticles. World J Gastroenterol 1999;5:330-3.
31. Cho CS, Kobayashi A, Takei R, et al. Receptor-mediated cell modulator delivery to hepatic using nanoparticles coated with carbohydrate-carryin polymers. Bioamaterials 2001;22:45-51.
32. Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93-102.
33. Murakami H, Kawashima Y, Niwa T, et al. Influence of the degrees of hydrolyzation and polymerization of poly(vinyl-alcohol)on the preparation and properties of poly(DL-lactide-co-glycolide) nanoparticle. Int J Pharm 1997;149:43-9.
34. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly (DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm 1999;187:143-52.
35. rd ed. New York: Marcel Dekker Inc; 1955;593-9, 611-80.
36. Feng SS, Mu L, Win KY, Huang G. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem 2004;11:413-24.
37. Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxols). J Control Release 2002;80:129-44.
38. Zhang Z, Mei L, Feng SS. Vitamin E D-a-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine. Nanomedicine 2012;7:1645-7.
39. Zhu H, Chen H, Zeng X, et al. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials 2014;35:2391-400.
40. Dobrozsi D. Oral liquid mucoadhesive compositions. US Patent Appl. No. 10/021, 327;2001.
41. Jin C, Bai L, Wu H, et al. Radio sensitization of paclitaxel, etanidazole and paclitaxel + etanidazole nanoparticles on hypoxic human tumor cells in vitro. Biomaterials 2007;28:3724-30.
42. Sengel-Türk CT, Hasçiçek C, Dogan AL, et al. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Drug Dev Ind Pharm 2012;38:1107-16.
43. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particle via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 2004;377:159-69.
44. Chen J, Li S, Shen Q, et al. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Drug Dev Ind Pharm 2011;37:1339-46.
45. Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005;26:2713-22.
46. Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release. 2008;130:98-106.
47. Yang Z, Sahay G, Sriadibhatla S, Kabanov AV. Amphiphilic block copolymers enhance cellular uptake and nuclear entry of polyplex-delivered DNA. Bioconjug Chem 2008;19:1987-94.
48. Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 2002;233:51-9.
49. Bogman K, Erne-Brand F, Alsenz J, Drewe J. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. J Pharm Sci 2003;92:1250-61.
50. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002;54:631-51.
51. Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 2002;16:237-46.
52. Bogman K, Zysset Y, Degen L, et al. P-glycoprotein and surfactants: effect on intestinal talinolol absorption. Clin Pharmacol Therap 2005;77:24-32.
53. Ma Y, Zheng Y, Zeng X, et al. Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment. Nanoscale Res Lett 2010;57:1161-9.